American College of Rheumatology Guidance for COVID ‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5
Methodological detailsmodified Delphi process, RAND/University of California Los Angeles Appropriateness Method, Task force of 9 rheumatologists/immunologists, 2 infectious diseases specialists and 2 public health physicians; evidence report; agreement rated on a 9-point scale over 2 sessions; consensus based on distribution of ratings
- Modified Delphi process
- RAND/University of California Los Angeles Appropriateness Method
- Task force of 9 rheumatologists/immunologists, 2 infectious diseases specialists and 2 public health physicians; evidence report; agreement rated on a 9-point scale over 2 sessions; consensus based on distribution of ratings
Recommendations
As issued by the authors
Guidance for use of the COVID-19 vaccines, including supplemental/booster dosing, in RMD patients
Recommendations regarding the use and timing of immunomodulatory therapies around the time of vaccination
Original publication
American College of Rheumatology Guidance for COVID ‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5. Arthritis Rheumatol. Published 8 November 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →